EUVIMEDOpdag EUVIMED
Crossref

From aging to cancer: a DNA methylation journey

Natalia Puig, Ruben Agrelo

Ageing Research · 2012

DOI: 10.4081/ar.2012.e4 ↗

At a glance

Journal article in Ageing Research, 2012. Written by Natalia Puig and 1 co-authors.

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Epigenetic gene silencing through DNA promoter hypermethylation is now recognised as a major step in the neoplastic transformation of the cell. The methylation levels of several genes increase with age in normal tissues such as the prostate or colon. Genes like WRN or LMNA that are involved in progeria,a premature aging disease WRN and LMNA, are epigenetically inactivated in cancer. In both aging and cancer, global DNA methylation decreases, potentially accounting for the characteristic genomic instability of these processes. In this review, we will focus on how the accumulation of changes in DNA methylation during aging impact tumourigenesis.

Cite

APA

Puig, N., & Agrelo, R. (2012). From aging to cancer: a DNA methylation journey. Ageing Research. https://doi.org/10.4081/ar.2012.e4

Vancouver

Puig N, Agrelo R. From aging to cancer: a DNA methylation journey. Ageing Research. 2012. doi:10.4081/ar.2012.e4

BibTeX
@article{Puig2012,
  author = {Puig, Natalia and Agrelo, Ruben},
  title = {From aging to cancer: a DNA methylation journey},
  journal = {Ageing Research},
  year = {2012},
  doi = {10.4081/ar.2012.e4}
}
Start for free →